drugset / Trial / NCT00055250
A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine in patients with pancreatic cancer.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ETALOCIB | Small molecule | — | — |
| Background | Gemcitabine | Small molecule | — | — |